Ha! I vote for the deliverance of a groin kick.
September 2017 could very well be when the rest of the world finally learns of a new & innovative and (hopefully) restorative treatment to benefit their family members suffering with debilitating CNS diseases.
Intuitively, there's quite a confluence of events and catalysts at the same time (new insider purchases plan & 30 day insider period up, patent receipt, pk/pd next, CNS partnering conference, 1 year anniversary of BIIB mta, trial announcements?).
I don't think it's coincidence.
In light of what they're looking to accomplish, and as you and I have discussed, Anavex Life Sciences can fully expect to have detractors and skeptics at every turn from this point forward.
I think it's likely a good sign that they are here actually.